AMAG - AMAG Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
326,164
474,002
609,946
532,091
418,276
Cost of Revenue
92,587
215,892
183,166
116,889
88,501
Gross Profit
233,577
258,110
426,780
415,202
329,775
Operating Expenses
Research Development
60,588
44,846
75,017
66,084
42,878
Selling General and Administrative
284,205
277,417
291,900
249,870
160,309
Total Operating Expenses
344,793
322,263
382,636
315,954
203,187
Operating Income or Loss
-111,216
-64,153
44,144
99,248
126,588
Interest Expense
25,770
51,971
68,382
73,153
53,251
Total Other Income/Expenses Net
-158,636
-18,889
-348,666
-20,189
-35,005
Income Before Tax
-289,851
-129,685
-370,094
9,055
39,844
Income Tax Expense
-2,576
39,654
-170,866
11,538
7,065
Income from Continuing Operations
-287,275
-169,339
-199,228
-2,483
32,779
Net Income
-288,805
-65,761
-199,228
-2,483
32,779
Net Income available to common shareholders
-288,805
-65,761
-199,228
-2,483
32,779
Reported EPS
Basic
-
-1.91
-5.71
-0.07
1.04
Diluted
-
-1.91
-5.71
-0.07
0.93
Weighted average shares outstanding
Basic
-
34,394
34,907
34,346
31,471
Diluted
-
34,394
34,907
34,346
35,308
EBITDA
-
94,509
-146,174
182,094
93,095